bluebird bio, Inc.
BLUE
$4.95
$0.061.23%
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Net Income | -240.72M | -292.83M | -319.25M | -300.65M | -211.91M |
Total Depreciation and Amortization | 61.24M | 56.20M | 48.27M | 37.82M | 28.53M |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 49.50M | 58.09M | 83.05M | 83.15M | -1.94M |
Change in Net Operating Assets | -130.05M | -85.46M | -57.19M | -58.69M | -49.72M |
Cash from Operations | -260.02M | -263.99M | -245.12M | -238.36M | -235.05M |
Capital Expenditure | -2.60M | -3.33M | -5.09M | -5.73M | -4.19M |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 6.50M | 8.55M | 71.92M | 77.89M | 159.14M |
Cash from Investing | 3.90M | 5.22M | 66.84M | 72.16M | 154.95M |
Total Debt Issued | 71.32M | 71.32M | 71.32M | 71.32M | -- |
Total Debt Repaid | -85.95M | -83.64M | -74.51M | -61.30M | -54.37M |
Issuance of Common Stock | -- | 118.23M | 118.23M | 118.23M | 248.88M |
Repurchase of Common Stock | -- | -- | -42.00K | -487.00K | -683.00K |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | 102.10M | 53.16M | 38.33M | 17.96M | 2.42M |
Cash from Financing | 87.47M | 159.06M | 153.33M | 145.72M | 196.25M |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -168.65M | -99.72M | -24.96M | -20.49M | 116.15M |